The Supreme Court has spoken: A jury’s $70 million award to a man who developed gynecomastia while taking Risperdal as a child will stand. Johnson & Johnson took the case to the highest court in the land after losing the initial case and an appeal.
The case was brought by Adam Yount. Yount was put on Risperdal at age four and began developing breast tissue by age five. According ...
continue reading...The Missouri Supreme Court declined to overturn a June 23 state appeals court decision that itself had allowed a July 2018 multi-billion dollar verdict to stand against Johnson & Johnson. The company was found liable for 22 women’s development of ovarian cancer. The diagnoses were argued to be the result of the presence of asbestos fibers in talc powder; an allegation long-since ...
With close to 20,000 cases pending against it, Johnson & Johnson may be the first wrong-doer to come to mind when it comes to the risk of asbestos contamination of the nation’s talc-based products. It is, however, far from the only culprit.
One of the others, German chemical company BASF, recently agreed to pay $72.5 million in its own settlement while simultaneously avoiding the admission of any wrongdoing ...
continue reading...It was the sixth largest financial award in the history of the country’s legal system. And while it has been cut in half by a Missouri appeals court, its implications for ongoing talc litigation are significant.
When a St. Louis jury awarded 22 women over $4.5 billion after finding that asbestos present in Johnson & Johnson talc-based hygiene products like Shower to Shower was responsible for their development of ovarian cancer, ...
continue reading...
The world’s largest healthcare goods manufacturer has pulled one of its cornerstone products from shelves across the United States and Canada. Amid an onslaught of lawsuits and having suffered strikingly large jury awards linking talc-based baby powder to mesothelioma, Johnson & Johnson will no longer sell its Baby Powder product in the two countries.
While the move is seen as a ...
continue reading...“In litigation of every nature, there are one-off situations where settlement is a reasonable alternative.” This was the cover Johnson & Johnson spokeswoman Kim Montagnino chose to hide behind after the corporation settled the talc-based asbestos case of California plaintiff Linda O’Hagan for $2 million. According to those familiar with the dealings, the offer to settle was made by Johnson ...
